These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9472635

  • 1. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
    Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M.
    Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S, Weller M.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
    [Abstract] [Full Text] [Related]

  • 3. Synergy of CD95 ligand and teniposide: no role of cleavable complex formation and enhanced CD95 expression.
    Winter S, Roth W, Dichgans J, Weller M.
    Eur J Pharmacol; 1998 Jan 12; 341(2-3):323-8. PubMed ID: 9543255
    [Abstract] [Full Text] [Related]

  • 4. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
    Roth W, Fontana A, Trepel M, Reed JC, Dichgans J, Weller M.
    Cancer Immunol Immunother; 1997 Mar 12; 44(1):55-63. PubMed ID: 9111585
    [Abstract] [Full Text] [Related]

  • 5. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.
    Weller M, Winter S, Schmidt C, Esser P, Fontana A, Dichgans J, Groscurth P.
    Int J Cancer; 1997 Nov 27; 73(5):707-14. PubMed ID: 9398050
    [Abstract] [Full Text] [Related]

  • 6. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
    Glaser T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M, Weller M.
    Br J Cancer; 1999 May 27; 80(5-6):756-65. PubMed ID: 10360653
    [Abstract] [Full Text] [Related]

  • 7. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U, Wagenknecht B, Naumann U, Weller M.
    Cell Physiol Biochem; 1999 May 27; 9(1):29-37. PubMed ID: 10352342
    [Abstract] [Full Text] [Related]

  • 8. Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells.
    Yuan SY, Hsu SL, Tsai KJ, Yang CR.
    Urol Res; 2002 Oct 27; 30(5):282-8. PubMed ID: 12389115
    [Abstract] [Full Text] [Related]

  • 9. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F, Knobbe CB, Frank B, Wolburg H, Weller M.
    Oncol Rep; 2008 Apr 27; 19(4):1061-6. PubMed ID: 18357397
    [Abstract] [Full Text] [Related]

  • 10. Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).
    Gonçalves A, Braguer D, Carles G, André N, Prevôt C, Briand C.
    Biochem Pharmacol; 2000 Dec 01; 60(11):1579-84. PubMed ID: 11077039
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.
    Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E.
    Mol Med; 1995 Jul 01; 1(5):506-26. PubMed ID: 8529117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
    Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R.
    Oncogene; 2001 Jan 11; 20(2):147-55. PubMed ID: 11313944
    [Abstract] [Full Text] [Related]

  • 16. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest.
    Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD, Pietenpol JA.
    J Biol Chem; 1998 Nov 13; 273(46):30777-84. PubMed ID: 9804855
    [Abstract] [Full Text] [Related]

  • 17. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P, Robey R, Fojo T, Blagosklonny MV.
    Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344
    [Abstract] [Full Text] [Related]

  • 18. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells.
    Roth W, Wagenknecht B, Dichgans J, Weller M.
    J Neuroimmunol; 1998 Jul 01; 87(1-2):121-9. PubMed ID: 9670853
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation.
    Pucci B, Bellincampi L, Tafani M, Masciullo V, Melino G, Giordano A.
    Exp Cell Res; 1999 Oct 10; 252(1):134-43. PubMed ID: 10502406
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K, Horwitz SB.
    Cancer Res; 1998 Aug 15; 58(16):3620-6. PubMed ID: 9721870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.